Elevated plasma renin activity predicts adverse outcome in chronic heart failure, independently of pharmacologic therapy: data from the Valsartan Heart Failure Trial (Val-HeFT).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples